<?xml version="1.0"?>
<rdf:RDF xmlns="http://ontofox.hegroup.org/akrt6v6h.owl#"
     xml:base="http://ontofox.hegroup.org/akrt6v6h.owl"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
     xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:obo="http://purl.obolibrary.org/obo/">
    <owl:Ontology rdf:about="http://ontofox.hegroup.org/akrt6v6h.owl"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#type"/>
    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#isDefinedBy"/>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P98">
        <rdfs:label>DesignNote</rdfs:label>
        <oboInOwl:hasExactSynonym>DesignNote</oboInOwl:hasExactSynonym>
        <obo:NCIT_P107>DesignNote</obo:NCIT_P107>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_NHC0>P98</obo:NCIT_NHC0>
        <obo:IAO_0000115>Design notes are notations made by NCI vocabulary curators. They are intended to provide supplemental, unstructured information to the user or additional insight about the concept.</obo:IAO_0000115>
        <obo:NCIT_P108>DesignNote</obo:NCIT_P108>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#is_metadata_tag"/>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/OPMI_0000364">
        <rdfs:label xml:lang="en">NCIT code</rdfs:label>
        <obo:IAO_0000115>An annotation property that refers to a code defined by NCIT</obo:IAO_0000115>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_NHC0">
        <rdfs:label>code</rdfs:label>
        <oboInOwl:hasExactSynonym>code</oboInOwl:hasExactSynonym>
        <obo:NCIT_P108>code</obo:NCIT_P108>
        <obo:NCIT_NHC0>NHC0</obo:NCIT_NHC0>
        <protege:readOnly>true</protege:readOnly>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000118">
        <rdfs:label>alternative term</rdfs:label>
        <rdfs:label xml:lang="en">alternative term</rdfs:label>
        <obo:IAO_0000115 xml:lang="en">An alternative name for a class or property which means the same thing as the preferred name (semantically equivalent)</obo:IAO_0000115>
        <obo:IAO_0000119 xml:lang="en">GROUP:OBI:&lt;http://purl.obolibrary.org/obo/obi&gt;</obo:IAO_0000119>
        <obo:IAO_0000117 xml:lang="en">PERSON:Daniel Schober</obo:IAO_0000117>
        <obo:IAO_0000111 xml:lang="en">alternative term</obo:IAO_0000111>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000125"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.obolibrary.org/obo/iao.owl"/>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000117">
        <rdfs:label>term editor</rdfs:label>
        <rdfs:label>definition editor</rdfs:label>
        <rdfs:label xml:lang="en">definition editor</rdfs:label>
        <rdfs:label xml:lang="en">term editor</rdfs:label>
        <obo:IAO_0000116 xml:lang="en">20110707, MC: label update to term editor and definition modified accordingly. See http://code.google.com/p/information-artifact-ontology/issues/detail?id=115.</obo:IAO_0000116>
        <obo:IAO_0000116 xml:lang="en">20110707, MC: label update to term editor and definition modified accordingly. See https://github.com/information-artifact-ontology/IAO/issues/115.</obo:IAO_0000116>
        <obo:IAO_0000119 xml:lang="en">GROUP:OBI:&lt;http://purl.obolibrary.org/obo/obi&gt;</obo:IAO_0000119>
        <obo:IAO_0000115 xml:lang="en">Name of editor entering the definition in the file. The definition editor is a point of contact for information regarding the term. The definition editor may be, but is not always, the author of the definition, which may have been worked upon by several people</obo:IAO_0000115>
        <obo:IAO_0000115 xml:lang="en">Name of editor entering the term in the file. The term editor is a point of contact for information regarding the term. The term editor may be, but is not always, the author of the definition, which may have been worked upon by several people</obo:IAO_0000115>
        <obo:IAO_0000117 xml:lang="en">PERSON:Daniel Schober</obo:IAO_0000117>
        <obo:IAO_0000111 xml:lang="en">definition editor</obo:IAO_0000111>
        <obo:IAO_0000111 xml:lang="en">term editor</obo:IAO_0000111>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.obolibrary.org/obo/iao.owl"/>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000119">
        <rdfs:label>definition source</rdfs:label>
        <rdfs:label xml:lang="en">definition source</rdfs:label>
        <obo:IAO_0000119 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w</obo:IAO_0000119>
        <obo:IAO_0000119 xml:lang="en">GROUP:OBI:&lt;http://purl.obolibrary.org/obo/obi&gt;</obo:IAO_0000119>
        <obo:IAO_0000117 xml:lang="en">PERSON:Daniel Schober</obo:IAO_0000117>
        <obo:IAO_0000111 xml:lang="en">definition source</obo:IAO_0000111>
        <obo:IAO_0000115 xml:lang="en">formal citation, e.g. identifier in external database to indicate / attribute source(s) for the definition. Free text indicate / attribute source(s) for the definition. EXAMPLE: Author Name, URI, MeSH Term C04, PUBMED ID, Wiki uri on 31.01.2007</obo:IAO_0000115>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.obolibrary.org/obo/iao.owl"/>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000114">
        <rdfs:label>has curation status</rdfs:label>
        <rdfs:label xml:lang="en">has curation status</rdfs:label>
        <obo:IAO_0000119 xml:lang="en">OBI_0000281</obo:IAO_0000119>
        <obo:IAO_0000117 xml:lang="en">PERSON:Alan Ruttenberg</obo:IAO_0000117>
        <obo:IAO_0000117 xml:lang="en">PERSON:Bill Bug</obo:IAO_0000117>
        <obo:IAO_0000117 xml:lang="en">PERSON:Melanie Courtot</obo:IAO_0000117>
        <obo:IAO_0000111 xml:lang="en">has curation status</obo:IAO_0000111>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000116">
        <rdfs:label>editor note</rdfs:label>
        <rdfs:label xml:lang="en">editor note</rdfs:label>
        <oboInOwl:is_metadata_tag rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</oboInOwl:is_metadata_tag>
        <oboInOwl:hasDbXref rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IAO:0000116</oboInOwl:hasDbXref>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">editor_note</oboInOwl:id>
        <oboInOwl:shorthand rdf:datatype="http://www.w3.org/2001/XMLSchema#string">editor_note</oboInOwl:shorthand>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">uberon</oboInOwl:hasOBONamespace>
        <obo:IAO_0000115 xml:lang="en">An administrative note intended for its editor. It may not be included in the publication version of the ontology, so it should contain nothing necessary for end users to understand the ontology.</obo:IAO_0000115>
        <obo:IAO_0000119 xml:lang="en">GROUP:OBI:&lt;http://purl.obfoundry.org/obo/obi&gt;</obo:IAO_0000119>
        <obo:IAO_0000117 xml:lang="en">PERSON:Daniel Schober</obo:IAO_0000117>
        <obo:IAO_0000111 xml:lang="en">editor note</obo:IAO_0000111>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.obolibrary.org/obo/iao.owl"/>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000412">
        <rdfs:label xml:lang="en">imported from</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">definition</rdfs:label>
        <rdfs:label>textual definition</rdfs:label>
        <rdfs:label xml:lang="en">definition</rdfs:label>
        <obo:IAO_0000111 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">definition</obo:IAO_0000111>
        <oboInOwl:hasExactSynonym>DEFINITION</oboInOwl:hasExactSynonym>
        <obo:IAO_0000116 xml:lang="en">2012-04-05: 
Barry Smith

The official OBI definition, explaining the meaning of a class or property: &#39;Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions&#39;  is terrible.

Can you fix to something like:

A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property.

Alan Ruttenberg

Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can&#39;t be evaluated by those criteria. 

On the specifics of the proposed definition:

We don&#39;t have definitions of &#39;meaning&#39; or &#39;expression&#39; or &#39;property&#39;. For &#39;reference&#39; in the intended sense I think we use the term &#39;denotation&#39;. For &#39;expression&#39;, I think we you mean symbol, or identifier. For &#39;meaning&#39; it differs for class and property. For class we want documentation that let&#39;s the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let&#39;s the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The &#39;intended reader&#39; part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition. 

Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable. 

We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with.  </obo:IAO_0000116>
        <obo:IAO_0000115>English language definitions of what NCI means by the concept. These are limited to 1024 characters. They may also include information about the definition&#39;s source and attribution in a form that can easily be interpreted by software.</obo:IAO_0000115>
        <obo:IAO_0000119 xml:lang="en">GROUP:OBI:&lt;http://purl.obolibrary.org/obo/obi&gt;</obo:IAO_0000119>
        <obo:IAO_0000117 xml:lang="en">PERSON:Daniel Schober</obo:IAO_0000117>
        <obo:IAO_0000115 xml:lang="en">The official OBI definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.</obo:IAO_0000115>
        <obo:IAO_0000111>textual definition</obo:IAO_0000111>
        <obo:IAO_0000115 xml:lang="en">The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.</obo:IAO_0000115>
        <obo:IAO_0000111 xml:lang="en">definition</obo:IAO_0000111>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.obolibrary.org/obo/iao.owl"/>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasDbXref">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">database_cross_reference</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000112">
        <rdfs:label>example of usage</rdfs:label>
        <rdfs:label xml:lang="en">example of usage</rdfs:label>
        <obo:IAO_0000115 xml:lang="en">A phrase describing how a class name should be used. May also include other kinds of examples that facilitate immediate understanding of a class semantics, such as widely known prototypical subclasses or instances of the class. Although essential for high level terms, examples for low level terms (e.g., Affymetrix HU133 array) are not</obo:IAO_0000115>
        <obo:IAO_0000115 xml:lang="en">A phrase describing how a term should be used and/or a citation to a work which uses it. May also include other kinds of examples that facilitate immediate understanding, such as widely know prototypes or instances of a class, or cases where a relation is said to hold.</obo:IAO_0000115>
        <obo:IAO_0000119 xml:lang="en">GROUP:OBI:&lt;http://purl.obolibrary.org/obo/obi&gt;</obo:IAO_0000119>
        <obo:IAO_0000117 xml:lang="en">PERSON:Daniel Schober</obo:IAO_0000117>
        <obo:IAO_0000111 xml:lang="en">example</obo:IAO_0000111>
        <obo:IAO_0000111 xml:lang="en">example of usage</obo:IAO_0000111>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.obolibrary.org/obo/iao.owl"/>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000111">
        <rdfs:label>editor preferred label</rdfs:label>
        <rdfs:label>editor preferred term~editor preferred label</rdfs:label>
        <rdfs:label>editor preferred term</rdfs:label>
        <rdfs:label xml:lang="en">editor preferred label</rdfs:label>
        <rdfs:label xml:lang="en">editor preferred term</rdfs:label>
        <obo:IAO_0000111>editor preferred term~editor preferred label</obo:IAO_0000111>
        <obo:IAO_0000111>editor preferred term</obo:IAO_0000111>
        <obo:IAO_0000111>editor preferred label</obo:IAO_0000111>
        <obo:IAO_0000119 xml:lang="en">GROUP:OBI:&lt;http://purl.obolibrary.org/obo/obi&gt;</obo:IAO_0000119>
        <obo:IAO_0000117 xml:lang="en">PERSON:Daniel Schober</obo:IAO_0000117>
        <obo:IAO_0000115 xml:lang="en">The concise, meaningful, and human-friendly name for a class or property preferred by the ontology developers. (US-English)</obo:IAO_0000115>
        <obo:IAO_0000111 xml:lang="en">editor preferred label</obo:IAO_0000111>
        <obo:IAO_0000111 xml:lang="en">editor preferred term</obo:IAO_0000111>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.obolibrary.org/obo/iao.owl"/>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#id"/>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasOBONamespace">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">has_obo_namespace</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasExactSynonym">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">has exact synonym</rdfs:label>
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">has_exact_synonym</rdfs:label>
        <obo:IAO_0000115>Fully qualified synonym, contains the string, term type, source, and an optional source code if appropriate. Each subfield is deliniated to facilitate interpretation by software.</obo:IAO_0000115>
        <oboInOwl:hasExactSynonym>Synonym with Source Data</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>FULL_SYN</oboInOwl:hasExactSynonym>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#shorthand">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">shorthand</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P106">
        <rdfs:label>Semantic_Type</rdfs:label>
        <oboInOwl:hasExactSynonym>Semantic_Type</oboInOwl:hasExactSynonym>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P107>Semantic Type</obo:NCIT_P107>
        <obo:NCIT_P108>Semantic_Type</obo:NCIT_P108>
        <obo:NCIT_NHC0>P106</obo:NCIT_NHC0>
        <obo:NCIT_P98>In general, applying semantic types aids in allowing users (or computer programs) to draw conclusions about concepts by virtue of the categories to which they have been assigned.  We use a set of semantic types developed for the UMLS Metathesaurus. There are currently 134 semantic types in the UMLS.</obo:NCIT_P98>
        <obo:IAO_0000115>The semantic type describes the sort of thing or category to which a concept belongs in the context of the UMLS semantic network.</obo:IAO_0000115>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#label">
        <rdfs:label>label</rdfs:label>
        <rdfs:label xml:lang="en">label</rdfs:label>
        <obo:IAO_0000111>label</obo:IAO_0000111>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P107">
        <rdfs:label>Display_Name</rdfs:label>
        <oboInOwl:hasExactSynonym>Display Name</oboInOwl:hasExactSynonym>
        <obo:NCIT_P107>Display Name</obo:NCIT_P107>
        <obo:NCIT_P108>Display_Name</obo:NCIT_P108>
        <obo:IAO_0000115>Provides an alternative Preferred Name for use in some NCI systems.</obo:IAO_0000115>
        <oboInOwl:hasExactSynonym>Display_Name</oboInOwl:hasExactSynonym>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_NHC0>P107</obo:NCIT_NHC0>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://protege.stanford.edu/plugins/owl/protege#readOnly"/>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P207">
        <rdfs:label>UMLS_CUI</rdfs:label>
        <obo:NCIT_NHC0>P207</obo:NCIT_NHC0>
        <obo:NCIT_P108>UMLS_CUI</obo:NCIT_P108>
        <obo:IAO_0000115>Concept Unique Identifiers, or CUIs, are concept numbers assigned by the National Library of Medicine (NLM). If a concept in any NCI-maintained knowledgebase exists in the NLM Unified Medical Language System (UMLS), NCI includes the NLM CUI among the information we provide about the concept.</obo:IAO_0000115>
        <oboInOwl:hasExactSynonym>UMLS_CUI</oboInOwl:hasExactSynonym>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P107>UMLS CUI</obo:NCIT_P107>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P108">
        <rdfs:label>Preferred_Name</rdfs:label>
        <oboInOwl:hasExactSynonym>Preferred Term</oboInOwl:hasExactSynonym>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P107>Preferred Name</obo:NCIT_P107>
        <obo:IAO_0000115>The word or phrase that NCI uses by preference to refer to the concept.</obo:IAO_0000115>
        <oboInOwl:hasExactSynonym>Preferred Name</oboInOwl:hasExactSynonym>
        <obo:NCIT_NHC0>P108</obo:NCIT_NHC0>
        <obo:NCIT_P108>Preferred_Name</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Preferred_Name</oboInOwl:hasExactSynonym>
    </owl:AnnotationProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Datatypes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Object Properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/IAO_0000136 -->

    <owl:ObjectProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
        <rdfs:label xml:lang="en">is about</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/OPMI_0000366 -->

    <owl:ObjectProperty rdf:about="http://purl.obolibrary.org/obo/OPMI_0000366">
        <rdfs:label xml:lang="en">has process quality</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/CTO_0000213 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000213">
        <rdfs:label xml:lang="en">USA National Clinical Trial identifier</rdfs:label>
        <obo:IAO_0000118>National Clinical Trial identifier</obo:IAO_0000118>
        <obo:IAO_0000119>https://www.nlm.nih.gov/bsd/policy/clin_trials.html</obo:IAO_0000119>
        <obo:IAO_0000118>NCT identifier</obo:IAO_0000118>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/about-site/link-to</obo:IAO_0000119>
        <obo:IAO_0000117>Qingliang Leon Li, Asiyah Yu Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000118>NCT number</obo:IAO_0000118>
        <obo:IAO_0000115>A centrally registered identifier that is assigned for a specific clinical trial registered in  the ClinicalTrials.gov. The format for the ClinicalTrials.gov registry number is “NCT” followed by an 8-digit number, e.g.: NCT00000419.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000217 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000217">
        <rdfs:label xml:lang="en">title of clinical trial</rdfs:label>
        <obo:IAO_0000115>A textual entity that is the title of a clinical trial</obo:IAO_0000115>
        <obo:IAO_0000119>https://prsinfo.clinicaltrials.gov/definitions.html</obo:IAO_0000119>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000219 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000219">
        <rdfs:label xml:lang="en">official title of clinical trial</rdfs:label>
        <obo:IAO_0000119>https://prsinfo.clinicaltrials.gov/definitions.html</obo:IAO_0000119>
        <obo:IAO_0000115>A title of clinical trial that is recorded as official</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000218 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000218">
        <rdfs:label xml:lang="en">lay title of clinical trial</rdfs:label>
        <obo:IAO_0000115>A title of clinical trial that is meant for lay people understanding</obo:IAO_0000115>
        <obo:IAO_0000119>https://prsinfo.clinicaltrials.gov/definitions.html</obo:IAO_0000119>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000214 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000214">
        <rdfs:label xml:lang="en">study start date</rdfs:label>
        <obo:IAO_0000115>The date on which a study starts</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000216 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000216">
        <rdfs:label xml:lang="en">clinical trial study completion date</rdfs:label>
        <obo:IAO_0000119>https://prsinfo.clinicaltrials.gov/definitions.html</obo:IAO_0000119>
        <obo:IAO_0000115>The date the final participant was examined or received an intervention for purposes of final collection of data for the primary and secondary outcome measures and adverse events (for example, last participant’s last visit), whether the clinical study concluded according to the pre-specified protocol or was terminated.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000215 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000215">
        <rdfs:label xml:lang="en">clinical trial primary completion date</rdfs:label>
        <obo:IAO_0000115>The date that the final participant was examined or received an intervention for the purposes of final collection of data for the primary outcome, whether the clinical study concluded according to the pre-specified protocol or was terminated. In the case of clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all of the primary outcomes.</obo:IAO_0000115>
        <obo:IAO_0000119>https://prsinfo.clinicaltrials.gov/definitions.html</obo:IAO_0000119>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000200 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000200">
        <rdfs:label xml:lang="en">clinical trial primary purpose specification</rdfs:label>
        <obo:IAO_0000115>The main objective of the intervention(s) being evaluated by the clinical trial.</obo:IAO_0000115>
        <obo:IAO_0000118>primary purpose of clinical trial</obo:IAO_0000118>
        <obo:IAO_0000119>https://prsinfo.clinicaltrials.gov/definitions.html</obo:IAO_0000119>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000209 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000209">
        <rdfs:label xml:lang="en">Japan clinical trial identifier</rdfs:label>
        <obo:IAO_0000119>https://pubchem.ncbi.nlm.nih.gov/source/NIPH%20Clinical%20Trials%20Search%20of%20Japan</obo:IAO_0000119>
        <obo:IAO_0000117>Qingliang Leon Li, Asiyah Yu Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>https://rctportal.niph.go.jp/en/</obo:IAO_0000119>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000212 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000212">
        <rdfs:label xml:lang="en">UMIN-CTR clinical trial identifier</rdfs:label>
        <obo:IAO_0000115>A Japan clinical trial identifier provided by the University Hospital Medical Information Network Center (UMIN-CTR)</obo:IAO_0000115>
        <obo:IAO_0000119>https://rctportal.niph.go.jp/en/</obo:IAO_0000119>
        <obo:IAO_0000117>Qingliang Leon Li, Asiyah Yu Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000210 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000210">
        <rdfs:label xml:lang="en">JAPIC clinical trial identifier</rdfs:label>
        <obo:IAO_0000117>Qingliang Leon Li, Asiyah Yu Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>https://rctportal.niph.go.jp/en/</obo:IAO_0000119>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000211 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000211">
        <rdfs:label xml:lang="en">JMACCT clinical trial identifier</rdfs:label>
        <obo:IAO_0000119>https://rctportal.niph.go.jp/en/</obo:IAO_0000119>
        <obo:IAO_0000117>Qingliang Leon Li, Asiyah Yu Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000208 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000208">
        <rdfs:label xml:lang="en">European clinical trial registry identifier</rdfs:label>
        <obo:IAO_0000119>https://en.wikipedia.org/wiki/EudraCT</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.clinicaltrialsregister.eu/ctr-search/search</obo:IAO_0000119>
        <obo:IAO_0000112>EudraCT Number: 2007-002422-29</obo:IAO_0000112>
        <obo:IAO_0000119>https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract</obo:IAO_0000119>
        <obo:IAO_0000117>Qingliang Leon Li, Asiyah Yu Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000118>EudraCT identifier</obo:IAO_0000118>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000201 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000201">
        <rdfs:label xml:lang="en">clinical trial phase</rdfs:label>
        <obo:IAO_0000117>Leon Li, Asiyah Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000115>The quality of a clinical trial that studies a drug or biological product. The phase is based on the study&#39;s objective, the number of participants, and other characteristics. According to USA FDA, there are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4.</obo:IAO_0000115>
        <obo:IAO_0000119>https://www.clinicaltrials.gov/ct2/help/glossary/phase</obo:IAO_0000119>
        <obo:IAO_0000118>clinical trial stage</obo:IAO_0000118>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000203 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000203">
        <rdfs:label xml:lang="en">clinical trial phase 1</rdfs:label>
        <obo:NCIT_P207>C0920321</obo:NCIT_P207>
        <obo:IAO_0000118>Phase 1</obo:IAO_0000118>
        <obo:OPMI_0000364>C15600</obo:OPMI_0000364>
        <obo:IAO_0000115>A clinical trial phase that represents the first-in-man trial, which tests within a small group of people (typically 20-80) to evaluate safety, determine safe dosage ranges, and begin to identify side effects. A drug&#39;s side effects could be subtle or long term, or may only happen with a few people, so phase 1 trials are not expected to identify all side effects.</obo:IAO_0000115>
        <obo:IAO_0000117>Leon Li, Asiyah Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>https://en.wikipedia.org/wiki/Clinical_trial</obo:IAO_0000119>
        <obo:IAO_0000119>http://purl.obolibrary.org/obo/NCIT_C15600</obo:IAO_0000119>
        <obo:IAO_0000118>Phase I</obo:IAO_0000118>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000204 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000204">
        <rdfs:label xml:lang="en">clinical trial phase 2</rdfs:label>
        <obo:IAO_0000119>https://en.wikipedia.org/wiki/Clinical_trial</obo:IAO_0000119>
        <obo:IAO_0000117>Leon Li, Asiyah Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>http://purl.obolibrary.org/obo/NCIT_C15601</obo:IAO_0000119>
        <obo:IAO_0000118>Phase II</obo:IAO_0000118>
        <obo:NCIT_P207>C0282460</obo:NCIT_P207>
        <obo:IAO_0000115>A clinical trial phase that is designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug&#39;s effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention. [def-source: NCI]</obo:IAO_0000115>
        <obo:OPMI_0000364>C15601</obo:OPMI_0000364>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000205 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000205">
        <rdfs:label xml:lang="en">clinical trial phase 3</rdfs:label>
        <obo:NCIT_P207>C0282461</obo:NCIT_P207>
        <obo:OPMI_0000364>C15602</obo:OPMI_0000364>
        <obo:IAO_0000115>A clinical trial phase that is designed to investigate the efficacy of the biomedical or behavioral intervention in large groups of human subjects (from several hundred to several thousand), to confirm efficacy, to monitor adverse reactions to the new medication or treatment regimen with respect to long-term use and by comparing the intervention to other standard or experimental interventions as well as to a placebo. [def-source: NCI]</obo:IAO_0000115>
        <obo:IAO_0000117>Leon Li, Asiyah Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>https://en.wikipedia.org/wiki/Clinical_trial</obo:IAO_0000119>
        <obo:IAO_0000119>http://purl.obolibrary.org/obo/NCIT_C15602</obo:IAO_0000119>
        <obo:IAO_0000118>Phase III</obo:IAO_0000118>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000206 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000206">
        <rdfs:label xml:lang="en">clinical trial phase 4</rdfs:label>
        <obo:IAO_0000117>Leon Li, Asiyah Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>https://en.wikipedia.org/wiki/Clinical_trial</obo:IAO_0000119>
        <obo:NCIT_P207>C0282462</obo:NCIT_P207>
        <obo:OPMI_0000364>C15603</obo:OPMI_0000364>
        <obo:IAO_0000115>A clinical trial phase that is designed for a randomized, controlled trial to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed. [def-source: NCI]</obo:IAO_0000115>
        <obo:IAO_0000118>Phase IV</obo:IAO_0000118>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000202 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000202">
        <rdfs:label>clinical trial early phase 1</rdfs:label>
        <obo:IAO_0000118>Pre-Clinical Phase</obo:IAO_0000118>
        <obo:IAO_0000118></obo:IAO_0000118>
        <obo:IAO_0000117>Leon Li, Asiyah Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>https://en.wikipedia.org/wiki/Clinical_trial</obo:IAO_0000119>
        <obo:IAO_0000118>Early Phase 1</obo:IAO_0000118>
        <obo:IAO_0000119>http://purl.obolibrary.org/obo/NCIT_C54721</obo:IAO_0000119>
        <obo:NCIT_P207>C1882358</obo:NCIT_P207>
        <obo:OPMI_0000364>C54721</obo:OPMI_0000364>
        <obo:IAO_0000115>A clinical trial phase that is designed to use an investigational agent that is available only in very limited quantities and which has never previously given to humans or for which there is extremely limited human experience. Phase 0 clinical trials are intended to enable researchers to understand the path of the drug in the body and its efficacy. Adverse event reporting in Phase 0 trials is expedited. [def-source: NCI]</obo:IAO_0000115>
        <obo:IAO_0000118 xml:lang="en">clinical trial phase 0</obo:IAO_0000118>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000220 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000220">
        <rdfs:label xml:lang="en">clinical trial</rdfs:label>
        <obo:IAO_0000119>https://en.wikipedia.org/wiki/Clinical_trial</obo:IAO_0000119>
        <obo:IAO_0000115>a clinical trial is a medical interventional study where participants are assigned prospectively to an intervention or interventions according to a protocol to evaluate the safety and efficacy of the intervention(s) on biomedical or other health related outcomes. The Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, preventive care, etc.</obo:IAO_0000115>
        <obo:IAO_0000119>https://www.who.int/ictrp/en/</obo:IAO_0000119>
        <obo:IAO_0000119>https://prsinfo.clinicaltrials.gov/definitions.html</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/search/map</obo:IAO_0000119>
        <obo:IAO_0000117>Oliver He, Asiyah Yu Lin, Qingliang Li</obo:IAO_0000117>
        <obo:IAO_0000118>interventional trial</obo:IAO_0000118>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000207 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000207">
        <rdfs:label xml:lang="en">Early Phase 1 clinical trial</rdfs:label>
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/OPMI_0000366"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/CTO_0000202"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <obo:IAO_0000115>A clinical trial that is at Early Phase 1 or Phase 0</obo:IAO_0000115>
        <obo:IAO_0000119>https://en.wikipedia.org/wiki/Clinical_trial</obo:IAO_0000119>
        <obo:IAO_0000118>Pre-Clinical Trial</obo:IAO_0000118>
        <obo:IAO_0000119>http://purl.obolibrary.org/obo/NCIT_C54721</obo:IAO_0000119>
        <obo:IAO_0000118>Phase 0 clinical trial</obo:IAO_0000118>
        <obo:IAO_0000115>A clinical trial that is at an Early Phase i or Phase 0, which is designed to use an investigational agent that is available only in very limited quantities and which has never previously given to humans or for which there is extremely limited human experience. Phase 0 clinical trials are intended to enable researchers to understand the path of the drug in the body and its efficacy. Adverse event reporting in Phase 0 trials is expedited. [def-source: NCI]</obo:IAO_0000115>
        <obo:IAO_0000117>Leon Li, Asiyah Lin, Oliver He</obo:IAO_0000117>
        <obo:IAO_0000118>Phase 0 trial</obo:IAO_0000118>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/opmi.owl"/>
    </owl:Class>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Individuals
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/IAO_0000122 -->

    <owl:NamedIndividual rdf:about="http://purl.obolibrary.org/obo/IAO_0000122">
        <rdfs:label xml:lang="en">ready for release</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000125 -->

    <owl:NamedIndividual rdf:about="http://purl.obolibrary.org/obo/IAO_0000125">
        <rdfs:label xml:lang="en">pending final vetting</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- http://purl.obolibrary.org/obo/iao.owl -->

    <owl:NamedIndividual rdf:about="http://purl.obolibrary.org/obo/iao.owl"/>
</rdf:RDF>



<!-- Generated by the OWL API (version 1.3.5.1016) http://owlapi.sourceforge.net -->

